1/82
A comprehensive set of vocabulary flashcards covering types of bipolar disorder, pharmacological treatments (including Lithium and anticonvulsants), nursing considerations, and suicide risk assessment/terminology based on the lecture notes.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Bipolar I Disorder
The most severe form of bipolar disorder, characterized by full manic episodes that last at least a week and occur all day, every day, often requiring hospitalization.
Cyclothymic Disorder
A chronically unstable mood state involving persistent patterns of mood fluctuations lasting at least 2 years.
Bipolar II Disorder
A type of bipolar disorder featuring hypomania and at least 1 depressive episode per year.
Mixed Features
The simultaneous presentation of mania (usually cognitive) and depression occurring together concurrently.
Rapid Cycling
A mood cycling pattern defined by 4 or more episodes of mania or depression within a single year.
Pressured speech
Rapid, urgent speech patterns commonly seen during manic episodes.
Flight of ideas
Racing thoughts characterized by jumping quickly between different ideas.
Hypomanic Episodes
A mood state involving increased energy and focus with a good mood, which is less extreme than mania and usually does not require hospitalization.
*easily irritated
Lithium (Lithobid)
Considered the gold standard mood stabilizer, it is used for manic and depressive episodes but requires regular monitoring due to a narrow therapeutic window.
Therapeutic Lithium Level
The safe therapeutic range for serum lithium levels, defined as 0.6−1.2mEq/L.
Severe Lithium Toxicity
A dangerous level of lithium in the blood, reaching 2.0mEq/L, which constitutes a medical emergency.
Lamotrigine (Lamictal)
An anticonvulsant mood stabilizer particularly effective for depressive episodes and generally the best tolerated in its class.
Stevens-Johnson Syndrome (SJS)
A rare and medical emergency involving a painful red or purplish rash that spreads and blisters, causing the skin to shed within days.
Atypical Antipsychotics
A class of medications, including Aripiprazole and Olanzapine, considered first-line treatment for acute manic episodes.
Tardive dyskinesia (TD)
A long-term complication of antipsychotic use involving involuntary, potentially irreversible muscle movements around the head, neck, and mouth.
Neuroleptic Malignant Syndrome (NMS)
A medical emergency associated with antipsychotic medication characterized by fever, confusion, muscle rigidity, and altered consciousness.
Suicide
The act of inflicting self-harm that results in death.
Suicidal Ideation
Thoughts about, consideration of, or plans for taking one's own life.
Non-suicidal Self-Injury (NSSI)
Self-directed injurious behavior performed without the intent to die.
SAD PERSONS
A mnemonic used for rapid suicide risk assessment, standing for Sex, Age, Depression, Previous attempts, Ethanol, Rational thinking loss, Social support lacking, Organized plan, No spouse, and Sickness.
IS PATH WARM
A mnemonic for suicide warning signs developed by the American Association of Suicidology: Ideation, Substance abuse, Purposelessness, Anxiety, Trapped, Hopelessness, Withdrawing, Anger, Recklessness, and Mood changes.
Passive death wish
A state of wanting to die but not actively pursuing or planning a method to kill oneself.
Contagion effect
The phenomenon where a suicide in media or peer groups may trigger similar suicidal behavior in others, particularly adolescents.
Valproate (Depakote)
An anticonvulsant mood stabilizer used primarily for managing bipolar disorder and effective in preventing manic and depressive episodes.
Carbamazepine (Tegretol)
An anticonvulsant used as a mood stabilizer, particularly effective in treating acute mania and rapid cycling patterns.
Nursing Consideration for Mood Stabilizers
Regular monitoring of blood levels, renal and liver function tests, and ensuring patient adherence to medication.
Patient Education for Mood Stabilizers
Inform patients about potential side effects, the importance of timely dosage, and not to stop medications abruptly without consulting a provider.
Cognitive Behavioral Therapy (CBT)
A type of psychotherapy that helps patients recognize and alter negative thought patterns and behaviors.
Active Listening
A therapeutic communication technique focusing on fully understanding and engaging with what the patient is expressing.
Empathy in Therapeutic Communication
The ability to understand and share the feelings of another, essential for building rapport with patients.
Validation
Acknowledging and affirming a patient's feelings and experiences to foster a safe communicative environment.
Intervention for Suicidal Ideation
Engaging in safety planning, providing resources, and mobilizing support systems to protect the patient.
Establishing Boundaries
Setting clear limits in therapeutic relationships to maintain a professional and safe environment for patients.
Antidepressants
Medications used to treat depressive disorders, which include SSRIs, SNRIs, and atypical antidepressants, and require monitoring for side effects and effectiveness.
Mood Stabilizers
Medications used to control mood swings, particularly in bipolar disorder, and include options like lithium, valproate, and carbamazepine.
SSRIs (Selective Serotonin Reuptake Inhibitors)
A class of antidepressants that increase serotonin levels to help improve mood and are usually the first-line treatment for depression.
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
A class of antidepressants that affect both serotonin and norepinephrine neurotransmitters, used for depression and anxiety disorders.
Atypical Antidepressants
A diverse group of antidepressants that do not fit neatly into other categories, each with unique mechanisms and side effects.
Safety Monitoring for Antipsychotics
Regular evaluation for metabolic syndrome, extrapyramidal symptoms, and other adverse effects in patients taking antipsychotic medications.
Psychiatric Emergency Interventions
Immediate actions taken to ensure patient safety, including crisis intervention and coordinate with emergency services when needed.
Therapeutic Relationship
A trusting, respectful partnership between the healthcare provider and patient, essential for effective treatment and communication.
Crisis Intervention Techniques
Strategies used to support individuals in acute distress, focusing on de-escalation and finding immediate solutions to safety concerns.
Documentation in Therapeutic Communication
Accurate, thorough records of interactions with patients to ensure continuity of care and legal compliance.
Mindfulness in Therapeutic Communication
The practice of being present and fully engaged with the patient during interactions, fostering a deeper understanding and connection.
Assertiveness Training
Teaching patients to express their needs and feelings confidently and indirectly, promoting self-advocacy in mental health care.
Bipolar I Disorder
The most severe form of bipolar disorder, characterized by full manic episodes that last at least a week and require hospitalization in many cases.
Bipolar II Disorder
A type of bipolar disorder featuring at least one major depressive episode and at least one hypomanic episode per year.
Lithium (Lithobid)
The gold standard mood stabilizer used for both manic and depressive episodes, necessitating regular blood level monitoring due to its narrow therapeutic window.
Lamotrigine (Lamictal)
An anticonvulsant mood stabilizer
effective for depressive episodes
Valproate (Depakote)
anticonvulsant mood stabilizer
Carbamazepine (Tegretol)
An anticonvulsant that is effective for treating acute mania and rapid cycling patterns typical in bipolar disorder.
REQUIRES MONITORING FOR DRUG INTERACTIONS
Atypical Antipsychotics Meds
Aripripazole
Olanzapine
Quetiapine
Risperidone
Ziprasidone
Rapid Cycling
A mood cycling pattern defined by four or more episodes of mania or depression occurring within a single year, common in bipolar disorder.
Manic episode characteristics
Euphoria
Decreased need for sleep
Pressured speech
Flight of ideas
Distractibility
Risky behavior
Irritability
Risk for Development of Bipolar Disorder
Equal in men and womenbut women may experience more depressive episodes, while men tend to have more manic episodes.
Children & adolescents LC
onset @ 18
*important to differentiate from typical adolescent mood swings
Pregnant Women LC
20% symptom recurrence
may experience first manic/depressive episode while pregnant
IMPORTANT: Carbamazepine & Valproic acid require modification
Older adults LC
Must rule out medical conditions including substance use disorder before diagnosis
BPD diagnostic approach
Clinical manifestations + patient history
NO test
BPD Primary Treatment Goal
Increasing function & quality of life
BPD Safety
Environmental modifications
Monitor for self-harm and suicidal ideation
Structured activities to safely burn off NRG
Use seclusion room strategically for time out rather than punishment
BPD Behavioral Management
AVOID competitive activities
Provide structured physical activities
Allow safe outlets for excess NRG [eg: punching bag]
BPD Cognitive Support
Promote reality-based thinking with consistency & acceptance
Positively-reinforce reality based thoughts & statements
Gently challenge delusions & grandiose thinking
Lithium Mechanism of Action
Affects flow of sodium through body cells; sodium affects reuptake of neurotransmittersLi
Lithium therapeutic uses
Mood stabilizer
Maintenance therapy
PROVEN to reduce BPD suicide risk
Lithium Dosing
Once daily
BID
TID
Lithium Onset
1-3 weeks
Lithium Interactions
NSAIDS
Diuretics
Caffeine
Carbamazepine
Antithyroid agents
Sodium
Lithium Adverse Effects
Tremors and GI
Polyuria/polydipsia
Weight gain
Dizziness, muslcel weakness, fatigue
Sexual dysfunctionLit
Lithium & Pregnancy
AVOID —> crosses the placenta
Toxicity Management Protocol
Hold dose
Obtain lithium level
Hydrate with normal saline
Correct electrolyte abnormalities
GI decontamination, whole-bowel irrigation
Symptomatic supportive care
Hemodialysis
Blood Level Monitoring Schedule
First month: 2-3 times/week
After first month: weekly
Long term: 2-3 months
When to obtain blood levels
After initialTi dose
After each dosage increase
5 days after a dosage adjustment
Timing of Blood Draws
Obtain level in the morning
12-14 hrs after last dose, minimum 8 hrs
Lifestyle & Dietary Management
2L-3L of fluid to prevent dehydration
Eat diet with consistent sodium intake
Avoid excesive coffee, tea, cola
Avoid activities causing excessive sweating
Low calorie diet options —> weight gain may occur
Driving & safety
May cause drowsiness or dizziness
Caution to avoid driving or activities requiring alertness until response to medication is known
Anticonvulsants as Mood Stabilizers
Valproic acid & Carbamazepine: more effective in treating mania
Lamotrigine: stronger antidepressent effect; best tolerated
Anticonvulsant Mood Stabilizer Adverse Effects
Can cause liver or kidney damage:
drowsiness
dizziness
fatigue
anorexia
weight gain
AC NC
Monitor liver functions regularly
Hepatotoxicity signs: anorexia, nausea & vomitng, fatigue, abdominal pain, jaundice
SJS
Monitor for low platlet count, low WBC, bone marrow suppression
Client Education AC
Do not breast feed when taking anticonvulsants
Sun protection
Use additional form of contraceptive
Don’t drive until med response is known
Monitor for suicidal behaviorLa
Lab Monitoring
LFTs
Platelet counts
Serum levels
Watch for pancreatitis: abd pain, nausea, vomiting, anorexiaAt
Atypical Antipsychotics Baseline
Monitor BP
Obtain baseline ECG
Monitor weight, glucose levels, and lipid levels
Atypical Antipsychotics SE
Sexual dysfunction
Concurrent medications: avoid using anticholinergic meds [antihistamines]